Eli Lilly's obesity drug retatrutide passes late-stage diabetes trial
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
health care industry
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. He wanted my help to build a platform on CNBC…
ACA Enrollees Left Uninsured After Enhanced Subsidies Expire: KFF Survey
Many Americans are feeling the financial pain following the expiration of enhanced federal subsidies for health insurance from the Affordable…
FDA approves high-dose version of Novo Nordisk's anti-obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
J&J's Icotyde Psoriasis Pill Rivals Tremfya Skyrizi IL-23 Injections
Signs outside the Johnson & Johnson offices in Irvine, California, U.S., on Friday, October 10, 2025. Kyle Grillot Bloomberg |…
Stopping GLP-1 increases cardiovascular risks: study
In a pharmacy you see boxes of Ozempic and Wegovy manufactured by Novo Nordisk. Hollie Adams | Reuters A version…
Eli Lilly Stock Falls After Analyst's Bearish Call: Here's Our Take
Eli Lilly shares fell 6% on Tuesday and are on track for their worst day since February after a downgrade…
Vertex kidney drug Povetacicept succeeds in IgAN trial
A sign hangs in front of Vertex Pharmaceuticals' global headquarters in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its…
FDA approves leucovorin for brain folate deficiency, but not autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a…
Novo Nordisk ends legal proceedings against Hims & Hers
Nordisk has dropped its legal case against telehealth provider him and her for patent infringement, after the two companies agreed…